Leinco Technologies, Inc.'s Anti-Human CD20 (Rituximab) - 50 mg is a Human monoclonal antibody. The Anti-Human CD20 (Rituximab) - 50 mg Antibody was generated using MS4A1 as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, Precipitation, ELISA, Flow Cytometry, Functional Assay, Immunoprecipitation, and Western Blot.